Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 70377-055

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 70377-055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (B201c94c 128a 4ae1 86a1 057c4c895839 01)

Chemical structure diagram of esomeprazole magnesium showing the molecular arrangement including two aromatic rings, sulfur, nitrogen, oxygen atoms, and magnesium complexed with three water molecules (Mg2+ · 3 H2O).*

FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (B201c94c 128a 4ae1 86a1 057c4c895839 02)

A line graph showing percentage maintained over 6 months for esomeprazole magnesium delayed-release capsules 40 mg compared to placebo. Four lines represent different sample sizes (N=91 to 98) for the drug and placebo (N=94). The graph depicts drug performance as consistently higher than placebo over time.*

FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (B201c94c 128a 4ae1 86a1 057c4c895839 03)

A line graph showing the percentage maintained over months for esomeprazole magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg strengths compared to placebo. The x-axis represents time in months (1 to 6), and the y-axis shows percent maintained. Higher doses show greater maintenance over time compared to placebo.*

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) Figure (B201c94c 128a 4ae1 86a1 057c4c895839 04)

A line chart comparing the percentage of patients symptom-free over 28 days among three groups: esomeprazole magnesium delayed-release capsules 40 mg, 20 mg, and a placebo group. The vertical axis represents the percent of patients symptom-free, and the horizontal axis shows diary days from 0 to 28.*

FDA Label Image

Image (B201c94c 128a 4ae1 86a1 057c4c895839 05)

Line graph depicting the percentage of patients symptom-free over 28 days comparing esomeprazole magnesium delayed-release capsules at 40 mg and 20 mg doses, and placebo. The x-axis represents diary days from 0 to 28, and the y-axis shows percent of patients symptom-free from 0 to 100%. Three lines track symptom-free percentages for each treatment group over time.*

FDA Label Image

Image (B201c94c 128a 4ae1 86a1 057c4c895839 06)

Label for Esomeprazole Magnesium Delayed-Release Capsules, USP, 20 mg, by Biocon Pharma Inc. The label includes dosing information, storage instructions, manufacturer details, and a barcode. The product is prescription only, with a package containing 30 capsules. It features the Biocon logo and states that each capsule contains 22.25 mg of esomeprazole magnesium trihydrate equivalent to 20 mg esomeprazole.*

FDA Label Image

Image (B201c94c 128a 4ae1 86a1 057c4c895839 07)

Label for Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg by Biocon Pharma Inc. The label specifies a 30-capsule bottle, with storage instructions, dosage form as delayed-release capsules, and includes a pharmacist dispensing note and barcode. Manufactured by Biocon Pharma Inc. in Iselin, NJ, and Graviti Pharmaceuticals Pvt. Ltd. in Telangana, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.